Back to top
more

GE HealthCare Technologies Inc. (GEHC)

(Delayed Data from NSDQ)

$70.74 USD

70.74
3,725,988

+0.10 (0.14%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $70.73 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (155 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Unveiling GE HealthCare (GEHC) Q3 Outlook: Wall Street Estimates for Key Metrics

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for GE HealthCare (GEHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.

Zacks Equity Research

GEHC Stock Declines Despite the Unveiling of CareIntellect Application

by Zacks Equity Research

GE Healthcare announces CareIntellect for Oncology to provide multi-modal patient data from disparate systems into a single view using generative AI.

Zacks Equity Research

GE HealthCare's Shares Rise After the Launch of Versana Premier

by Zacks Equity Research

GEHC launches Versana Premier, an AI-powered ultrasound system with advanced features designed for efficient, high-quality diagnostics across multiple specialties.

Zacks Equity Research

AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe

by Zacks Equity Research

ATRC's EnCompass Clamp receives a CE Mark, enabling European surgeons to access faster, simpler heart ablation in cardiac surgeries with advanced radiofrequency technology.

Zacks Equity Research

GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business

by Zacks Equity Research

GEHC acquires clinical AI business to aid its ultrasound portfolio with AI-driven image analysis tools.

Zacks Equity Research

GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod

by Zacks Equity Research

GE Healthcare's MIM Software announces the FDA clearance of Monte Carlo Dosimetry for Theranostics, enhancing precision in personalized treatment plans.

Zacks Equity Research

InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent

by Zacks Equity Research

NSPR gains premarket approval for its CGuard Prime carotid stent system for use in United States for treating carotid artery stenosis.

Zacks Equity Research

Reasons to Retain GE HealthCare Stock in Your Portfolio Now

by Zacks Equity Research

GEHC's continued focus on innovations, acquisitions and partnerships raise optimism about the stock.

Zacks Equity Research

GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado

by Zacks Equity Research

GEHC's Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.

Zacks Equity Research

GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch

by Zacks Equity Research

GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.

Zacks Equity Research

GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool

by Zacks Equity Research

GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.

Shilpa Mete headshot

Can Cloud Momentum Drive Amazon's Stock Beyond Its 14.1% YTD Gain?

by Shilpa Mete

Amazon rides on AWS strength, driven by an expanding portfolio, a strong customer base and its Generative AI drive.

Zacks Equity Research

GE Healthcare to Unveil AI-Driven Cardiac Diagnostics at ESC 2024

by Zacks Equity Research

GEHC launches AI-enhanced ultrasound and ECG-less Cardiac CT technologies, offering rapid, accurate cardiac diagnostics at the point of care.

Zacks Equity Research

GE HealthCare's (GEHC) Tie-Up to Boost Female Pelvic Healthcare

by Zacks Equity Research

GE HealthCare's (GEHC) latest collaboration is likely to equip clinicians with a toolset to deliver enhanced care to female patients and improve the patient experience.

Zacks Equity Research

Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

GE HealthCare (GEHC) Q2 Earnings Beat Estimates, Net Margin Up

by Zacks Equity Research

GE HealthCare's (GEHC) second-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.

Zacks Equity Research

Here's What Key Metrics Tell Us About GE HealthCare (GEHC) Q2 Earnings

by Zacks Equity Research

While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

GE HealthCare Technologies (GEHC) Tops Q2 Earnings Estimates

by Zacks Equity Research

GE HealthCare (GEHC) delivered earnings and revenue surprises of 2.04% and 1.03%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Indrajit Bandyopadhyay headshot

Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?

by Indrajit Bandyopadhyay

Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, XRAY, GEHC and GKOS are placed ahead of their earnings release.

Zacks Equity Research

Lower Volume Likely to Hurt GE HealthCare's (GEHC) Q2 Earnings

by Zacks Equity Research

GE HealthCare's (GEHC) second-quarter results are likely to witness declining segmental revenues in imaging, ultrasound and patient care. The bottom-line results may reflect better pricing.

Zacks Equity Research

GE HealthCare (GEHC) New Deal to Aid Its Ultrasound Portfolio

by Zacks Equity Research

GE HealthCare (GEHC) announces that it has entered into an agreement to acquire Intelligent Ultrasound's AI software business to strengthen its ultrasound portfolio.

Sheraz Mian headshot

Top Analyst Reports for Berkshire Hathaway, McDonald's & American Express

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), McDonald's Corporation (MCD) and American Express Company (AXP), as well as a micro-cap stock Steel Partners Holdings L.P. (SPLP).

Zacks Equity Research

GE HealthCare's (GEHC) New Solution to Aid Prostate Treatment

by Zacks Equity Research

GE HealthCare's (GEHC) MIM Software introduced the MIM Symphony HDR Prostate to provide direct tumor visualization using MRI images during live ultrasound procedures for HDR prostate treatments.

Zacks Equity Research

GE Healthcare (GEHC) Enters Partnership to Boost MRI Technology

by Zacks Equity Research

GE Healthcare's (GEHC) alliance is likely to establish an Innovative MRI Research and Development center to advance MRI innovation and patient care

Zacks Equity Research

GE HealthCare's (GEHC) New Tie-Up to Boost CVD Workflow

by Zacks Equity Research

GE HealthCare's (GEHC) latest collaboration is likely to enable clinicians to perform complex cardiology interventions with a high level of precision and improved image quality.